72 related articles for article (PubMed ID: 33355644)
1. Estimating Cured Fractions of Uveal Melanoma.
Singh AD; Zabor EC; Radivoyevitch T
JAMA Ophthalmol; 2021 Feb; 139(2):174-181. PubMed ID: 33355644
[TBL] [Abstract][Full Text] [Related]
2. SF3B1 mutations are associated with alternative splicing in uveal melanoma.
Furney SJ; Pedersen M; Gentien D; Dumont AG; Rapinat A; Desjardins L; Turajlic S; Piperno-Neumann S; de la Grange P; Roman-Roman S; Stern MH; Marais R
Cancer Discov; 2013 Oct; 3(10):1122-1129. PubMed ID: 23861464
[TBL] [Abstract][Full Text] [Related]
3. A molecular revolution in uveal melanoma: implications for patient care and targeted therapy.
Harbour JW; Chao DL
Ophthalmology; 2014 Jun; 121(6):1281-8. PubMed ID: 24480708
[TBL] [Abstract][Full Text] [Related]
4. Uveal melanoma: From diagnosis to treatment and the science in between.
Chattopadhyay C; Kim DW; Gombos DS; Oba J; Qin Y; Williams MD; Esmaeli B; Grimm EA; Wargo JA; Woodman SE; Patel SP
Cancer; 2016 Aug; 122(15):2299-312. PubMed ID: 26991400
[TBL] [Abstract][Full Text] [Related]
5. Update on uveal melanoma: Translational research from biology to clinical practice (Review).
Ortega MA; Fraile-Martínez O; García-Honduvilla N; Coca S; Álvarez-Mon M; Buján J; Teus MA
Int J Oncol; 2020 Dec; 57(6):1262-1279. PubMed ID: 33173970
[TBL] [Abstract][Full Text] [Related]
6. Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma.
Harbour JW; Roberson ED; Anbunathan H; Onken MD; Worley LA; Bowcock AM
Nat Genet; 2013 Feb; 45(2):133-5. PubMed ID: 23313955
[TBL] [Abstract][Full Text] [Related]
7. Second Primary Neoplasms in Patients With Uveal Melanoma: A SEER Database Analysis.
Laíns I; Bartosch C; Mondim V; Healy B; Kim IK; Husain D; Miller JW
Am J Ophthalmol; 2016 May; 165():54-64. PubMed ID: 26940164
[TBL] [Abstract][Full Text] [Related]
8. Uveal Melanoma UK National Guidelines.
Nathan P; Cohen V; Coupland S; Curtis K; Damato B; Evans J; Fenwick S; Kirkpatrick L; Li O; Marshall E; McGuirk K; Ottensmeier C; Pearce N; Salvi S; Stedman B; Szlosarek P; Turnbull N;
Eur J Cancer; 2015 Nov; 51(16):2404-12. PubMed ID: 26278648
[TBL] [Abstract][Full Text] [Related]
9. Outcome Measures of New Technologies in Uveal Melanoma: Review from the European Vision Institute Special Interest Focus Group Meeting.
Beenakker JM; Brouwer NJ; Chau C; Coupland SE; Fiorentzis M; Heimann H; Heufelder J; Joussen AM; Kiilgaard JF; Kivelä TT; Piperno-Neumann S; Rantala ES; Romanowska-Dixon B; Shields CL; Willerding GD; Wheeler-Schilling T; Scholl HPN; Jager MJ; Damato BE;
Ophthalmic Res; 2023; 66(1):14-26. PubMed ID: 35358966
[TBL] [Abstract][Full Text] [Related]
10. Uveal Melanoma Treatment and Prognostication.
Dogrusöz M; Jager MJ; Damato B
Asia Pac J Ophthalmol (Phila); 2017; 6(2):186-196. PubMed ID: 28399342
[TBL] [Abstract][Full Text] [Related]
11. Update on Ophthalmic Oncology 2014: Retinoblastoma and Uveal Melanoma.
Francis JH; Levin AM; Abramson DH
Asia Pac J Ophthalmol (Phila); 2016; 5(5):368-82. PubMed ID: 27632029
[TBL] [Abstract][Full Text] [Related]
12. Clustering of uveal melanoma: County wide analysis within Ohio.
Clevenger LM; Wrenn JD; Bena J; Sodhi G; Tullio K; Singh AD
PLoS One; 2023; 18(8):e0290284. PubMed ID: 37594976
[TBL] [Abstract][Full Text] [Related]
13. Long-Read Sequencing Reveals Alternative Splicing-Driven, Shared Immunogenic Neoepitopes Regardless of SF3B1 Status in Uveal Melanoma.
Yao T; Zhang Z; Li Q; Huang R; Hong Y; Li C; Zhang F; Huang Y; Fang Y; Cao Q; Jin X; Li C; Wang Z; Lin XJ; Li L; Wei W; Wang Z; Shen J
Cancer Immunol Res; 2023 Dec; 11(12):1671-1687. PubMed ID: 37756564
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive causes of death in uveal melanoma: mortality in 1530 consecutively diagnosed patients followed until death.
Stålhammar G
JNCI Cancer Spectr; 2023 Oct; 7(6):. PubMed ID: 37972025
[TBL] [Abstract][Full Text] [Related]
15. Obesity paradox in uveal melanoma: high body mass index is associated with low metastatic risk.
Sabazade S; Opalko A; Herrspiegel C; Gill VT; Plastino F; André H; Stålhammar G
Br J Ophthalmol; 2024 Mar; 108(4):578-587. PubMed ID: 37028917
[TBL] [Abstract][Full Text] [Related]
16. Costs associated with treating uveal melanoma are understudied.
Crump RT; Khan A; Weis E
Can J Ophthalmol; 2023 Dec; 58(6):e240-e241. PubMed ID: 37488052
[No Abstract] [Full Text] [Related]
17. Worldwide Incidence of Ocular Melanoma and Correlation With Pigmentation-Related Risk Factors.
Wu M; Yavuzyigitoglu S; Brosens E; Ramdas WD; Kiliç E;
Invest Ophthalmol Vis Sci; 2023 Oct; 64(13):45. PubMed ID: 37902747
[TBL] [Abstract][Full Text] [Related]
18. The Surveillance, Epidemiology, and End Results (SEER) Program and Pathology: Toward Strengthening the Critical Relationship.
Duggan MA; Anderson WF; Altekruse S; Penberthy L; Sherman ME
Am J Surg Pathol; 2016 Dec; 40(12):e94-e102. PubMed ID: 27740970
[TBL] [Abstract][Full Text] [Related]
19. Uveal Melanoma and the IRIS® Registry (Intelligent Research in Sight): A Pilot Analysis and Future Directions.
Uner OE; Aronow ME; Mruthyunjaya P; Materin MA; Stacey AW; Wilson M; Afshar A; Skalet AH
Ophthalmol Retina; 2023 Mar; 7(3):284-286. PubMed ID: 36522810
[No Abstract] [Full Text] [Related]
20. Correction to: BAP1 mutant uveal melanoma is stratified by metabolic phenotypes with distinct vulnerability to metabolic inhibitors.
Han A; Purwin TJ; Bechtel N; Liao C; Chua V; Seifert E; Sato T; Schug ZT; Speicher DW; Harbour JW; Aplin AE
Oncogene; 2021 Mar; 40(9):1753. PubMed ID: 33510355
[No Abstract] [Full Text] [Related]
[Next] [New Search]
